Skip to main content

2019 Timeline of Media Reports on New Developments in HIV and STI Health


2019 Timeline of Reports on New Developments in HIV and STI Health



1.       10 January : Comments on U=U by NIH Director

2.       9 May Trump Administration secures historic donation of billions of dollars in HIV prevention drugs

3.       26 June: Congressional Committee on Oversight and Reform begins investing where Trump administration made a deal with Gilead

4.       26 September: LGBT Life Center reports record high increases in STI and HIV rates

5.       3 October FDA approves Descovy

6.       7 October: California rolls out free PrEP and PEP to all citizens without a prescription

7.       8 October: News13 report highest incidences of STIs


Comments

Popular posts from this blog

Community Practicum Project: Part 1-3

As a scholar with specific subject matter expertise in anthropology and public health, and as an individual living with HIV, a first generation college student, and queer man with history of substance abuse whose work and life are deeply intertwined, I have derived a lot of comfort and hope in bearing witness to the power of community coalitions while accompanying community leaders and advocates in mobilizing to take care of one another, to act, and to engage in necessary fights around issues that have long been in existence: universal and meaningful healthcare, abolition, housing rights, equal employment, gender equality, environmental justice, and rights of marginalized communities, displaced populations, migrants and immigrants. I have worked alongside community leaders, activists, and health and social providers in the field of HIV and disease prevention who have long refused to accept the status quo, and have instead, created their own forms of care or reimagined the existing sy

The War on Sex: Some Notes

  The War on Sex Sex is an important site of social control, adjudication, and- ultimately -oppression. Many social movement organizations have focused on sexual health and do not generally frame their work in terms of social justice or civil rights. The failed attempts to decriminalize HIV in the Virginia legislature, both within and outside the General Assembly, are both troubling and deserving of critical examination, and yet they are just pieces of a much larger puzzle comprising legal, social, and economic systems that do not readily seem to fit together. Institutional ethnography: Interrelationships among the General Assembly, Virginia Department of Health, and community organizations working to repeal the laws criminalizing HIV in the Commonwealth are each a subject of analysis here… The Problems of Prospective: “Thinking Sex”                 From the beginning, this issue was not seen for what it truly was and is: a war on sex.                 By only problematizin

The Economic Burden of AIDS in America: Increasing Access to HIV Medicines

The Economic Burden of AIDS in America: Increasing Access to HIV Medicines Clay Porter Eastern Virginia Medical School Abstract This paper examines the cost of the HIV epidemic in America and surmises the economic benefits of an early targeted roll out of treatment for minority communities. By assessing the literature on health disparities in accessing HIV/AIDS medicines and the financial toll of medical costs associated with HIV-related complications, it is determined that increased access will reduce the economic burden of the virus on both at risk communities and the health services systems they rely on. The Economic Burden of AIDS in America: Increasing Access to HIV Medicines There are an estimated 1.1 million individuals living with human immunodeficiency virus (HIV) infection in the United States, and about 66% of this population are not engaged in medical care (CDC, 2014). This disparity is extreme, with black and Hispanic communities, specifical